AI Article Synopsis
- Bevacizumab is a cancer treatment that works by inhibiting vascular epidermal growth factor and is associated with side effects like hypertension and bleeding.
- Rare skin reactions, such as exfoliative dermatitis, have been reported with this medication.
- A specific case is presented where a patient with metastatic colon cancer developed cutaneous lupus likely caused by bevacizumab, which started to improve after stopping chemotherapy, highlighting the importance of prompt medical attention.
Article Abstract
Bevacizumab, an anti-vascular epidermal growth factor inhibitor, is approved for the treatment of various cancers. Hypertension, gastrointestinal perforation, bleeding manifestations, impaired wound healing, and cerebrovascular accidents are common side effects associated with the monoclonal antibody. Uncommon cutaneous reactions like exfoliative dermatitis associated with bevacizumab have been documented in the medical literature. We present an unusual case of bevacizumab-induced cutaneous lupus in a patient with metastatic colon cancer that started resolving after discontinuing chemotherapy. Timely intervention was key in preventing the progression of this chemotherapy-induced cutaneous lupus.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11028020 | PMC |
| http://dx.doi.org/10.7759/cureus.56559 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A photodistributed rash in a patient on apixaban.
JAAD Case Rep
January 2025
Department of Dermatology, VCU Health System, Richmond, Virginia.
Phototoxic reaction to oral terbinafine due to Tinea capitis in a child.
Acta Dermatovenerol Croat
November 2024
Prof. Ana Bakija-Konsuo, MD, PhD, Clinic for Dermatovenerology CUTIS, Vukovarska 22, Dubrovnik, Croatia;
We report the case of an 18-month-old boy who developed a phototoxic skin reaction to terbinafine on his scalp, ears, and face in the form of disseminated erythematous plaques, which resembled subacute lupus erythematosus (SCLE) in their clinical presentation. Skin changes appeared a short time after the boy was exposed to sunlight during the period of time when he was treated with oral terbinafine due to Microsporum canis fungal scalp infection. Tinea capitis is a common dermatophyte infection primarily affecting prepubertal children (1).
View Article and Find Full Text PDFCase report: Diagnostic challenges of papulonodular mucinosis in a 67-year-old female.
SAGE Open Med Case Rep
January 2025
Division of Dermatology, University of Saskatchewan College of Medicine, Saskatoon, SK, Canada.
Papulonodular mucinosis is a rare dermatological condition characterized by mucin deposition in the dermis, leading to the formation of papules and nodules that can occur with, or antedate, autoimmune connective tissue diseases. This case report presents a 67-year-old female with a chronic history of cutaneous mucinosis, which posed significant diagnostic challenges. Despite various treatments and extensive diagnostic workup, her condition evolved, highlighting the difficulties in diagnosing papulonodular mucinosis, especially in the absence of systemic lupus erythematosus and antinuclear antibody positivity.
View Article and Find Full Text PDFSuccessful treatment of recalcitrant cutaneous lupus erythematosus with anifrolumab in patients without systemic lupus erythematosus.
JAAD Case Rep
January 2025
Department of Dermatology, University of Florida College of Medicine, Gainesville, Florida.
Epidemiology of discoid lupus erythematosus among adults in the United States: a cross-sectional analysis.
Int J Dermatol
January 2025
Department of Dermatology, Rutgers Robert Wood Johnson Medical School, Piscataway, NJ, USA.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!